|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Echovirus IgA ELISA | Anti-Etanercept (Enbrel®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Epstein-Barr Virus (EBNA-1) IgM ELISA | PMN Elastase ELISA Assay |
| Catalog Number | IB05048 | TM09007 | TM09036 | IB79860 | IB79187 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgA antibodies directed against ECHO viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Etanercept (Enbrel®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay for the determination of IgM-class antibodies to Epstein-Barr virus nuclear-1 antigen (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Solid phase enzyme immunometric assay (ELISA) for the determination of PMN elastase in EDTA or citrated plasma, exudate, bronchoalveolar lavage fluid, cerebrospinal fluid and seminal plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Echovirus IgA | PSA (Free) | sAPP Total | Schistosoma mansoni IgG | HE4 |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 0 / 3 - 1000 ng/mL | Anti-Ustekinumab (Stelara®) | A cut-off control is used for the interpretation of results. | 15.6 to 1000 ng/mL |
| Sensitivity | > 95% | Inquire | 0.06 ng/mL | 93.75% (95% confidence interval: 82.8% - 98.69%) | < 25 pM. |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hrs 20 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |